Efficacy and safety of anticoagulant therapy in sepsis: A systematic review and meta-analysis

Sepsis and Coagulation: Is It Time to Put the Heparin Away?

Is "thinning the blood" the missing piece in the sepsis puzzle, or just a recipe for disaster? Sepsis triggers a deadly cascade of inflammation and clotting, yet the debate over therapeutic anticoagulation has left ICU clinicians caught between the potential for organ salvage and the perilous risk of hemorrhage. In this episode, we break down a 2026 systematic review and meta-analysis from the *Journal of International Medical Research*. The investigators pooled data from 10 major studies—including 8 randomized controlled trials—covering nearly 7,500 adult patients to determine if agents like heparin, antithrombin III, or recombinant thrombomodulin actually save lives. The verdict? We discuss why the data shows that routine anticoagulation in unselected sepsis patients offers **no significant mortality benefit** and trends toward a higher risk of major bleeding. We also unpack a critical discrepancy: while observational studies suggested a survival advantage, the rigorous RCTs flatly contradicted this, exposing the dangers of selection bias. Join us as we explore why the "one-size-fits-all" approach to sepsis anticoagulation is officially dead and why future hopes now rest entirely on high-risk subgroups like those with disseminated intravascular coagulation (DIC). Tune in to get the evidence you need to make safer decisions at the bedside.